Table 1 Subject groups for analysis
From: Methylation age acceleration does not predict mortality in schizophrenia
SCZ-died | SCZ-alive | Control-died | Control-alive | |
|---|---|---|---|---|
Criteria | SCZ with ≥5 specialist treatment contacts for SCZ or SAD & ≥5 antipsychotic prescriptions | No lifetime SCZ, SAD, or bipolar disorder or antipsychotic prescriptions | ||
N | 127 | 63 | 127 | 63 |
Age at sampling | 45–65 years | 45–65 years | 45–85 years | 45–65 years |
Follow up | Died ≥1 year after sampling | Alive ≥3 years after sampling | Died ≥1 year after sampling | Alive ≥3 years after sampling |
Exclusion | Removed deaths by suicide, accident, or violence | None | Removed deaths by suicide, accident, or violence | None |
